UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Microbiome in Inflammatory Bowel Disease

Journal of clinical medicine, 2024-08, Vol.13 (16), p.4622

2024

Volltextzugriff (PDF)

Role of Intestinal Ultrasound in the Management of Patients with Inflammatory Bowel Disease

Life (Basel, Switzerland), 2021-06, Vol.11 (7), p.603

2021

Volltextzugriff (PDF)

Practical Approaches to “Top–Down” Therapies for Crohn’s Disease

Current gastroenterology reports, 2016-07, Vol.18 (7), p.35-35, Article 35

2016

Volltextzugriff (PDF)

The Impact of Vedolizumab and Ustekinumab on Articular Extra-Intestinal Manifestations in Inflammatory Bowel Disease Patients: A Real-Life Multicentre Cohort Study

Journal of Crohn's and colitis, 2022-11, Vol.16 (11), p.1676-1686

2022

Volltextzugriff (PDF)

Lessons to learn from Crohn's disease clinical trials: implications for ulcerative colitis

Current drug targets, 2011-09, Vol.12 (10), p.1467-1477

2011

Volltextzugriff (PDF)

Safety and Effectiveness of Vedolizumab and Ustekinumab in Elderly Patients with Inflammatory Bowel Disease: A Real-Life Multicentric Cohort Study

Journal of clinical medicine, 2024-01, Vol.13 (2), p.365

2024

Volltextzugriff (PDF)

IL-22-Activated MUC13 Impacts on Colonic Barrier Function through JAK1/STAT3, SNAI1/ZEB1 and ROCK2/MAPK Signaling

Cells (Basel, Switzerland), 2023-04, Vol.12 (9), p.1224

2023

Volltextzugriff (PDF)

Cell therapies for IBD: what works?

Current drug targets, 2013-11, Vol.14 (12), p.1453-1459

2013

Volltextzugriff (PDF)

MUCIN MRNA ISOFORM SIGNATURES AS POTENTIAL NOVEL BIOMARKERS TO EVALUATE DISEASE STATUS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

Gastroenterology (New York, N.Y. 1943), 2024-02, Vol.166 (3), p.S89-S90

2024

Volltextzugriff (PDF)

MUCIN MRNA ISOFORM SIGNATURES AS POTENTIAL NOVEL BIOMARKERS TO EVALUATE DISEASE STATUS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

Inflammatory bowel diseases, 2024-01, Vol.30 (Supplement_1), p.S65-S65

2024

Volltextzugriff (PDF)

A Simplified Geboes Score for Ulcerative Colitis

Journal of Crohn's and colitis, 2016-08, p.jjw154

2016

Volltextzugriff (PDF)

Sa1635 Capsule Endoscopy (CE) Is Superior to Magnetic Resonance Enterography (MRE) for the Assessment of Small Bowel Lesions in Crohn's Disease Patients (CD): a Comparative Trial

Gastrointestinal endoscopy, 2013-05, Vol.77 (5), p.AB275-AB275

2013

Volltextzugriff (PDF)

Su1501: PROPHYLACTIC VERSUS ENDOSCOPY DRIVEN TREATMENT OF CROHN'S POSTOPERATIVE RECURRENCE: A RETROSPECTIVE MULTICENTRIC EUROPEAN STUDY

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-602-S-603

2022

Volltextzugriff (PDF)

Characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imaging

The American journal of gastroenterology, 2015-03, Vol.110 (3), p.432-440

2015

Volltextzugriff (PDF)

Accuracy of Magnetic Resonance Enterography in Assessing Response to Therapy and Mucosal Healing in Patients With Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2014-02, Vol.146 (2), p.374-382.e1

2014

Volltextzugriff (PDF)

Tu1815 IL-22-ACTIVATED JAK1/STAT3-INDUCED MUC13 OVEREXPRESSION COULD AFFECT INTESTINAL MUCOSAL BARRIER FUNCTION THROUGH THE SNAI1/ZEB1 AND ROCK2/MAPK SIGNALLING AXES

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-1142-S-1142

2023

Volltextzugriff (PDF)

Position statement on the management of the immune checkpoint inhibitor-induced colitis via multidisciplinary modified Delphi consensus

European journal of cancer (1990), 2023-07, Vol.187, p.36-57

2023

Volltextzugriff (PDF)

Use of biologics and chemotherapy in patints with inflammatory bowel diseases and cancer

Annals of gastroenterology, 2016, Vol.29 (2)

Jauregui-Amezaga, Aranzazu

2016

Volltextzugriff (PDF)

93 MRI is a Valuable Tool for Identification of Fibrosis in Patients With Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-22-S-23

2012

Volltextzugriff (PDF)

Intraperitoneal Administration of Autologous Tolerogenic Dendritic Cells for Refractory Crohn’s Disease: A Phase I Study

Journal of Crohn's and colitis, 2015-12, Vol.9 (12), p.1071-1078

2015

Volltextzugriff (PDF)

A Simplified Geboes Score for Ulcerative Colitis

Journal of Crohn's and colitis, 2017-03, Vol.11 (3), p.305-313

2017

Volltextzugriff (PDF)

Risk of developing tuberculosis under anti-TNF treatment despite latent infection screening

Journal of Crohn's and colitis, 2013-04, Vol.7 (3), p.208-212

2013

Volltextzugriff (PDF)

The intestinal mucin isoform landscape reveals region-specific biomarker panels for inflammatory bowel disease patient stratification

Journal of Crohn's and colitis, 2024-09

2024

Volltextzugriff (PDF)

In-Depth Study of Transmembrane Mucins in Association with Intestinal Barrier Dysfunction During the Course of T Cell Transfer and DSS-Induced Colitis

Journal of Crohn's and colitis, 2020-07, Vol.14 (7), p.974-994

2020

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(48)

Sprache

Englisch
(47)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The Microbiome in Inflammatory Bowel Disease

Role of Intestinal Ultrasound in the Management of Patients with Inflammatory Bowel Disease

Practical Approaches to “Top–Down” Therapies for Crohn’s Disease

The Impact of Vedolizumab and Ustekinumab on Articular Extra-Intestinal Manifestations in Inflammatory Bowel Disease Patients: A Real-Life Multicentre Cohort Study

Lessons to learn from Crohn's disease clinical trials: implications for ulcerative colitis

Safety and Effectiveness of Vedolizumab and Ustekinumab in Elderly Patients with Inflammatory Bowel Disease: A Real-Life Multicentric Cohort Study

IL-22-Activated MUC13 Impacts on Colonic Barrier Function through JAK1/STAT3, SNAI1/ZEB1 and ROCK2/MAPK Signaling

Cell therapies for IBD: what works?

MUCIN MRNA ISOFORM SIGNATURES AS POTENTIAL NOVEL BIOMARKERS TO EVALUATE DISEASE STATUS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

MUCIN MRNA ISOFORM SIGNATURES AS POTENTIAL NOVEL BIOMARKERS TO EVALUATE DISEASE STATUS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

A Simplified Geboes Score for Ulcerative Colitis

Sa1635 Capsule Endoscopy (CE) Is Superior to Magnetic Resonance Enterography (MRE) for the Assessment of Small Bowel Lesions in Crohn's Disease Patients (CD): a Comparative Trial

Su1501: PROPHYLACTIC VERSUS ENDOSCOPY DRIVEN TREATMENT OF CROHN'S POSTOPERATIVE RECURRENCE: A RETROSPECTIVE MULTICENTRIC EUROPEAN STUDY

Characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imaging

Accuracy of Magnetic Resonance Enterography in Assessing Response to Therapy and Mucosal Healing in Patients With Crohn's Disease

Tu1815 IL-22-ACTIVATED JAK1/STAT3-INDUCED MUC13 OVEREXPRESSION COULD AFFECT INTESTINAL MUCOSAL BARRIER FUNCTION THROUGH THE SNAI1/ZEB1 AND ROCK2/MAPK SIGNALLING AXES

Position statement on the management of the immune checkpoint inhibitor-induced colitis via multidisciplinary modified Delphi consensus

Use of biologics and chemotherapy in patints with inflammatory bowel diseases and cancer

93 MRI is a Valuable Tool for Identification of Fibrosis in Patients With Crohn's Disease

Intraperitoneal Administration of Autologous Tolerogenic Dendritic Cells for Refractory Crohn’s Disease: A Phase I Study

A Simplified Geboes Score for Ulcerative Colitis

Risk of developing tuberculosis under anti-TNF treatment despite latent infection screening

The intestinal mucin isoform landscape reveals region-specific biomarker panels for inflammatory bowel disease patient stratification

In-Depth Study of Transmembrane Mucins in Association with Intestinal Barrier Dysfunction During the Course of T Cell Transfer and DSS-Induced Colitis

Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn's disease

Suchergebnisse filtern